Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Prostate Cancer
and you are
over 18
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.

Provided treatments

  • Drug: Apalutamide
  • Drug: LHRH Analogue
  • Drug: Abiraterone Acetate
  • Drug: Prednisone
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03009981. The sponsor of the trial is Alliance Foundation Trials, LLC. and it is looking for 504 volunteers for the current phase.
Official trial title:
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer